Global Whole Genome and Exome Sequencing Market

Focus on Product, Workflow, Application, End User, Country Data (16 Countries), and Competitive Landscape - Analysis and Forecast, 2019-2029

Published Year: 2020
SKU: BHP1020SA

5000

Online Access for One Person. Permission to Print

A quick peek into the report

Table of Contents

Download this TOC  

Request a Sample

1 Product Definition

      1.1   Whole Genome Sequencing

      1.2   Whole Exome Sequencing

      1.3   Inclusion and Exclusion

2 Research Scope

      2.1   Scope of the Study

      2.2   Key Questions Answered in the Report

3 Research Methodology

      3.1   Primary Data Sources

      3.2   Secondary Data Sources

      3.3   Market Estimation Model

      3.4   Criteria for Company Profiling

4 Industry Insights

      4.1   Overview

     4.2   Legal Requirements and Framework in the U.S.

     4.3   Legal Requirements and Framework in Europe

     4.4   Legal Requirements and Framework in Asia-Pacific

             4.4.1   Japan

5 Competitive Landscape

      5.1   Mergers and Acquisitions

      5.2   Product Launches and Product Updates

      5.3   Synergistic Activities

      5.4   Business Expansion Activities and Others

      5.5   Market Share Analysis

      5.6   Growth Share Analysis

6 Market Dynamics

      6.1   Overview

      6.2   Impact Analysis

      6.3   Market Drivers

              6.3.1   Rising Prevalence of Genetic Disorders

              6.3.2   Increasing Prevalence of Various Types of Cancer, Globally

              6.3.3   Increasing Research Funding in the Field of Genomics

      6.4   Market Restraints

              6.4.1   Expensive Sequencing Procedures and Their Applications in Medical Treatments

              6.4.2   High Capital Requirement Hampering the Expansion of Global Reach

              6.4.3   Stringent Regulatory Standards

      6.5   Market Opportunities

              6.5.1   Technological Advancements in Sample Preparation for Whole Genome and Exome Sequencing

              6.5.2   Opportunity (by Product)

                         6.5.2.1   Kits

              6.5.3   Opportunity (by Application)

                         6.5.3.1   DNA Sequencing

                         6.5.3.2   Metagenomics

7 Global Whole Genome and Exome Sequencing Market Overview

      7.1   Introduction

      7.2   Market Availability for Whole Genome and Exome Sequencing Market

      7.3   Whole Genome and Exome Sequencing Market Technology Trends

8 Global Whole Genome and Exome Sequencing Market (by Product)

      8.1   Overview

      8.2   Kits

              8.2.1   Library Preparation Kits

              8.2.2   Target Enrichment Kits

      8.3   Instruments

9 Global Whole Genome and Exome Sequencing Market (by Workflow)

     9.1   Whole Genome Sequencing (WGS): By Workflow

              9.1.1   WGS: Sample Extraction/Isolation/Purification

              9.1.2   WGS: Library Preparation

              9.1.3   WGS: Library Quantification

              9.1.4   Analysis (Bioinformatics)

                         9.1.4.1   Services

                         9.1.4.2   Platforms

      9.2   Whole Exome Sequencing: By Workflow

              9.2.1   WES: Sample Extraction/Isolation/Purification

                         9.2.1.1   Targeted Sequencing

                         9.2.1.2   Amplicon-Based Sequencing

                         9.2.1.3   Capture-Based Sequencing

              9.2.2   WES: Library Preparation

              9.2.3   WES: Library Quantification

              9.2.4   Analysis (Bioinformatics)

                         9.2.4.1   Services

                         9.2.4.2   Platforms

10 Global Whole Genome and Exome Sequencing Market (by Application)

        10.1   Overview

        10.2   Whole Genome Sequencing (WGS)

                  10.2.1   Oncology Sequencing

                  10.2.2   Microbial Sequencing

                  10.2.3   NIPT Sequencing

        10.3   Whole Exome Sequencing (WES)

                  10.3.1   Oncology Sequencing

                  10.3.2   Rare Diseases Sequencing

                  10.3.3   Translational Research Sequencing

11 Global Whole Genome and Exome Sequencing Market (by End User)

        11.1   Overview

        11.2   Research Centres, Academia and Government Institutes

        11.3   Diagnostic Labs

        11.4   Pharmaceutical and Biotechnology Companies

        11.5   Hospitals and Clinics

        11.6   Other End Users

12 Global Whole Genome and Exome Sequencing Market (by Region)

        12.1   Overview

        12.2   North America

                  12.2.1   U.S.

                  12.2.2   Canada

        12.3   Europe

                  12.3.1   Germany

                  12.3.2   France

                  12.3.3   U.K.

                  12.3.4   Italy

                  12.3.5   Spain

                  12.3.6   Netherlands

                  12.3.7   Russia

                  12.3.8   Rest-of-Europe

        12.4   Asia-Pacific

                  12.4.1   China

                  12.4.2   Japan

                  12.4.3   Australia

                  12.4.4   India

                  12.4.5   Singapore

                  12.4.6   Rest-of-APAC

         12.5   Latin America

                  12.5.1   Brazil

                  12.5.2   Mexico

                  12.5.3   Rest-of-Latin America

        12.6   Rest-of-the-World

13 Company Profiles

        13.1   Overview

        13.2   Agilent Technologies, Inc.

                  13.2.1   Company Overview

                  13.2.2   Role of Agilent Technologies, Inc. in the Global Whole Genome and Exome Sequencing Market

                  13.2.3   Financials

                  13.2.4   Key Insights about Financial Health of the Company

                  13.2.5   SWOT Analysis

        13.3   Beijing Genomics Institute (BGI)

                  13.3.1   Company Overview

                  13.3.2   Role of BGI in the in the Global Whole Genome and Exome Sequencing Market

                  13.3.3   SWOT Analysis

        13.4   Bio-Rad Laboratories, Inc.

                  13.4.1   Company Overview

                  13.4.2   Role of Bio-Rad Laboratories, Inc. in the Global Whole Genome and Exome Sequencing Market

                  13.4.3   Financials

                               13.4.3.1   Key Insights about Financial Health of the Company

                  13.4.4   SWOT Analysis

        13.5   Cancer Genetics, Inc.

                  13.5.1   Company Overview

                  13.5.2   Role of Cancer Genetics, Inc. in the Global Whole Genome and Exome Sequencing Market

                  13.5.3   Financials

                  13.5.4   Key Insights about Financial Health of the Company

                  13.5.5   SWOT Analysis

        13.6   Eurofins Scientific SE

                  13.6.1   Company Overview

                  13.6.2   Role of Eurofins Scientific SE in the Global Whole Genome and Exome Sequencing Market

                  13.6.3   Financials

                  13.6.4   SWOT Analysis

        13.7   F. Hoffmann-La Roche Ltd

                  13.7.1   Company Overview

                  13.7.2   Role of F. Hoffmann-La Roche Ltd in the Global Genome and Exome Sequencing Market

                  13.7.3   Financials

                  13.7.4   Key Insights About Financial Health of the Company

                  13.7.5   SWOT Analysis

        13.8   General Electric Company

                  13.8.1   Company Overview

                  13.8.2   Role of General Electric Company in the Global Genome and Exome Sequencing Market

                  13.8.3   Financials

                  13.8.4   Key Insights about Financial Health of the Company

                  13.8.5   SWOT Analysis

        13.9   GENEWIZ, Inc.

                  13.9.1   Company Overview

                  13.9.2   Role of GENEWIZ, Inc. in the Global Whole Genome and Exome Sequencing Market

                  13.9.3   SWOT Analysis

      13.10   Illumina, Inc.

                  13.10.1   Company Overview

                  13.10.2   Role of Illumina, Inc. in the Global Whole Genome and Exome Sequencing Market

                  13.10.3   Financials

                  13.10.4   Key Insights about Financial Health of the Company

                  13.10.5   SWOT Analysis

       13.11   Laboratory Corporation of America Holdings

                  13.11.1   Company Overview

                  13.11.2   Role of Laboratory Corporation of America Holdings in the Global Whole Genome and Exome Sequencing Market

                  13.11.3   Financials

                  13.11.4   SWOT Analysis

      13.12   Novogene Corporation

                  13.12.1   Company Overview

                  13.12.2   Role of Novogene Corporation in the Global Whole Genome and Exome Sequencing Market

                  13.12.3   SWOT Analysis

      13.13   Oxford Nanopore Technologies, Inc.

                  13.13.1   Company Overview

                  13.13.2   Role of Oxford Nanopore Technologies, Inc. in the Global Whole Genome and Exome Sequencing Market

                  13.13.3   SWOT Analysis

      13.14   Pacific Biosciences of California, Inc.

                  13.14.1   Company Overview

                  13.14.2   Role of Pacific Biosciences of California, Inc. in the Global Whole Genome and Exome Sequencing Market

                  13.14.3   Financials

                  13.14.4   Key Insights About Financial Health of the Company

                  13.14.5   SWOT Analysis

      13.15   QIAGEN N.V.

                  13.15.1   Company Overview

                  13.15.2   Role of QIAGEN N.V. in the Global Whole Genome and Exome Sequencing Market

                  13.15.3   Financials

                  13.15.4   Key Insights about Financial Health of the Company

                  13.15.5   SWOT Analysis

      13.16   Thermo Fisher Scientific Inc.

                  13.16.1   Company Overview

                  13.16.2   Role of Thermo Fisher Scientific Inc. in the Global Whole Genome and Exome Sequencing Market

                  13.16.3   Financials

                  13.16.4   Key Insights about Financial Health of the Company

                  13.16.5   SWOT Analysis

14 Appendix

   14.1   Related Reports

List of Tables

Table 1:    Per Sample Clinical Cost of WGS and WES
Table 6.1:    Impact Analysis
Table 8.1:    Key Products and Application in Whole Genome and Exome Sequencing Market

List of Figures

Figure 1:    Impact of Market Drivers and Market Restraints on the Global Whole Genome and Exome Sequencing Market
Figure 2:    Global Whole Genome and Exome Sequencing Market (by Product), 2018 vs. 2029 ($Million)
Figure 3:    Global Whole Genome and Exome Sequencing Market (by End User), 2018 vs. 2029 ($Million)
Figure 4:    Global Whole Genome and Exome Sequencing Market Snapshot, 2018 and 2029 ($Million)
Figure 2.1:    Global Whole Genome and Exome Sequencing Market Segmentation
Figure 3.1:    Global Whole Genome and Exome Sequencing Market Methodology
Figure 3.2:    Primary Research Methodology
Figure 3.3:    Bottom-Up Approach (Segment-Wise Analysis)
Figure 4.1:    Regulatory Scenario in Europe (by Country)
Figure 4.2:    Assessment of Commercialization Strategy in Japan
Figure 5.1:    Share of Key Developments and Strategies, January 2017–February 2020
Figure 5.2:    Number of Product Launches (by Company), January 2016–December 2019
Figure 5.3:    Synergistic Activities Share (by Company), January 2017–February 2020
Figure 5.4:    Business Expansion Activities Share (by Company), January 2017–February 2020
Figure 5.5:    Market Share Analysis for the Global Whole Genome and Exome Sequencing Market, 2018
Figure 5.6:    Growth Share Matrix for Global Whole Genome and Exome Sequencing Market (by Company), 2017-2018
Figure 6.1:    People Suffering from CF (Cystic Fibrosis), 2002-2017:
Figure 6.2:    Number of Deaths (in Millions) by Different Forms of Cancer, 2018
Figure 6.3:    Global Whole Genome and Exome Sequencing Market (Kits), 2019 and 2029
Figure 6.4:    Global Whole Genome and Exome Sequencing Market (by Application:), 2019 and 2029
Figure 8.1:    Global Whole Genome and Exome Sequencing Market (by Product)
Figure 8.2:    Global Whole Genome and Exome Sequencing Market (Kits), 2018-2029
Figure 8.3:    Global Whole Genome and Exome Sequencing Market (Library Preparation Kits), 2018-2029
Figure 8.4:    Global Whole Genome and Exome Sequencing Market (Target Enrichment Kits), 2018-2029
Figure 8.5:    Global Whole Genome and Exome Sequencing Market (Instruments),  2018-2029
Figure 9.1:    Global Whole Genome and Exome Sequencing Market (WGS: Sample Extraction/Isolation/Purification), 2018-2029
Figure 9.2:    Global Whole Genome and Exome Sequencing Market (WGS: Library Preparation), 2018-2029
Figure 9.3:    Global Whole Genome and Exome Sequencing Market (by WGS: Library Quantification), 2018-2029
Figure 9.4:    Global Whole Genome and Exome Sequencing Market (by Analysis), 2018-2029
Figure 9.5:    Global Whole Genome and Exome Sequencing Market (by WGS: Analysis: Services), 2018-2029
Figure 9.6:    Global Whole Genome and Exome Sequencing Market (WGS: Analysis: Platforms), 2018-2029
Figure 9.7:    Global Whole Genome and Exome Sequencing Market (by WES: Sample Extraction/Isolation/Purification), 2018-2029
Figure 9.8:    Global Whole Genome and Exome Sequencing Market (by WES: Sample Extraction: Targeted Sequencing), 2018-2029
Figure 9.9:    Global Whole Genome and Exome Sequencing Market (WES: Sample Extraction: Amplicon Based Sequencing), 2018-2029
Figure 9.10:    Global Whole Genome and Exome Sequencing Market (WES: Sample Extraction: Capture Based Sequencing), 2018-2029
Figure 9.11:    Global Whole Genome and Exome Sequencing Market (WGS: Library Preparation), 2018-2029
Figure 9.12:    Global Whole Genome and Exome Sequencing Market (WES: Library Quantification), 2018-2029
Figure 9.13:    Global Whole Genome and Exome Sequencing Market (WES: Analysis: Services), 2018-2029
Figure 9.14:    Global Whole Genome and Exome Sequencing Market (WES: Analysis: Paid Sources), 2018-2029
Figure 10.1:    Global Whole Genome and Exome Sequencing Market (by Application)
Figure 10.2:    Global Whole Genome and Exome Sequencing Market (Oncology Sequencing),2018-2029
Figure 10.3:    Global Whole Genome and Exome Sequencing Market (Microbial Sequencing),2018-2029
Figure 10.4:    Global Whole and Exome Sequencing Market (NIPT),2018-2029
Figure 10.5:    Global Whole Genome and Exome Sequencing Market (Oncology Sequencing),2018-2029
Figure 10.6:    Global Whole Genome and Exome Sequencing Market (Rare Diseases Sequencing),2018-2029
Figure 10.7:    Global Whole Genome and Exome Sequencing Market (Translational Research Sequencing),2018-2029
Figure 11.1:    Global Whole Genome and Exome Sequencing Market (by End User)
Figure 11.2:    Global Market (Research Centres, Academia, and Government Institutes), 2018-2029
Figure 11.3:    Global Whole Genome and Exome Sequencing Market (Diagnostic Labs), 2018-2029
Figure 11.4:    Global Whole Genome and Exome Sequencing Market (Pharmaceutical and Biotechnology Companies), 2018-2029
Figure 11.5:    Global Whole Genome and Exome Sequencing Market (Hospitals and Clinics), 2018-2029
Figure 11.6:    Global Whole Genome and Exome Sequencing Market (Other End Users), 2018-2029
Figure 12.1:    Global Whole Genome and Exome Sequencing Market (by Region), 2018 and 2029
Figure 12.2:    Global Whole Genome and Exome Sequencing Market (by Region), 2018-2029
Figure 12.3:    Global Whole Genome and Exome Sequencing Market Share (by Region), 2018
Figure 12.4:    Global Whole Genome and Exome Sequencing Market Share (by Region), 2029
Figure 12.5:    North America Whole Genome and Exome Sequencing Market, 2018-2029
Figure 12.6:    North America: Market Dynamics
Figure 12.7:    North America Whole Genome and Exome Sequencing Market (by Country), 2018-2029
Figure 12.8:    U.S. Whole Genome and Exome Sequencing Market, 2018-2029
Figure 12.9:    Canada Whole Genome and Exome Sequencing Market, 2018-2029
Figure 12.10:    Europe Whole Genome and Exome Sequencing Market, 2018-2029
Figure 12.11:    Europe: Market Dynamics
Figure 12.12:    Europe Whole Genome and Exome Sequencing Market (by Country),  2018-2029
Figure 12.13:    Germany Whole Genome and Exome Sequencing Market, 2018-2029
Figure 12.14:    France Whole Genome and Exome Sequencing Market, 2018-2029
Figure 12.15:    U.K. Whole Genome and Exome Sequencing Market, 2018-2029
Figure 12.16:    Italy Whole Genome and Exome Sequencing Market, 2018-2029
Figure 12.17:    Spain Whole Genome and Exome Sequencing Market, 2018-2029
Figure 12.18:    Netherlands Whole Genome and Exome Sequencing Market, 2018-2029
Figure 12.19:    Russia Whole Genome and Exome Sequencing Market, 2018-2029
Figure 12.20:    Rest-of-Europe Whole Genome and Exome Sequencing Market, 2018-2029
Figure 12.21:    Asia-Pacific Whole Genome and Exome Sequencing Market, 2018-2029
Figure 12.22:    APAC: Market Dynamics
Figure 12.23:    APAC Whole Genome and Exome Sequencing Market (by Country),  2018-2029
Figure 12.24:    China Whole Genome and Exome Sequencing Market, 2018-2029
Figure 12.25:    Japan Whole Genome and Exome Sequencing Market, 2018-2029
Figure 12.26:    Australia Whole Genome and Exome Sequencing Market, 2018-2029
Figure 12.27:    India Whole Genome and Exome Sequencing Market, 2018-2029
Figure 12.29:    Singapore Whole Genome and Exome Sequencing Market, 2018-2029
Figure 12.30:    RoAPAC Whole Genome and Exome Sequencing Market, 2018-2029
Figure 12.31:    Latin America Whole Genome and Exome Sequencing Market, 2018-2029
Figure 12.32:    Latin America: Market Dynamics
Figure 12.33:    Latin America Whole Genome and Exome Sequencing Market (by Country), 2018-2029
Figure 12.34:    Brazil Whole Genome and Exome Sequencing Market, 2018-2029
Figure 12.35:    Mexico Whole Genome and Exome Sequencing Market, 2018-2029
Figure 12.36:    Rest-of-Latin America Whole Genome and Exome Sequencing Market,  2018-2029
Figure 12.37:    RoW Whole Genome and Exome Sequencing Market, 2018-2029
Figure 13.1:    Total Number of Companies Profiled
Figure 13.2:    Agilent Technologies, Inc.: Product Portfolio
Figure 13.3:    Agilent Technologies, Inc.: Overall Financials, 2016-2018
Figure 13.4:    Agilent Technologies, Inc.: Revenue (by Segment), 2016-2018
Figure 13.5:    Agilent Technologies, Inc.: Revenue (by Region), 2016-2018
Figure 13.6:    Agilent Technologies, Inc.: R&D Expenditure, 2016-2018
Figure 13.7:    Agilent Technologies, Inc.: SWOT Analysis
Figure 13.8:    BGI:Product Portfolio
Figure 13.9:    BGI: SWOT Analysis
Figure 13.10:    Bio-Rad Laboratories, Inc.: Product Offerings
Figure 13.11:    Bio-Rad Laboratories, Inc.: Overall Financials, 2016-2018
Figure 13.12:    Bio-Rad Laboratories, Inc.: Revenue (by Segment), 2016-2018
Figure 13.13:    Bio-Rad Laboratories, Inc.: Revenue (by Region), 2016-2018
Figure 13.14:    Bio-Rad Laboratories, Inc.: R&D Expenditure, 2016-2018
Figure 13.15:    Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 13.16:    Cancer Genetics, Inc.; Product Portfolio:
Figure 13.17:    Cancer Genetics, Inc.: Overall Financials, 2016-2018
Figure 13.18:    Cancer Genetics, Inc.: Revenue (by Segment), 2016-2018
Figure 13.19:    Cancer Genetics, Inc.: R&D Expenditure, 2016-2018
Figure 13.20:    Cancer Genetics, Inc.: SWOT Analysis
Figure 13.21:    Eurofins Scientific SE: Overall Financials, 2016-2018
Figure 13.22:    Eurofins Scientific SE: Revenue (by Region), 2016-2018
Figure 13.23:    Eurofins Scientific SE.: SWOT Analysis
Figure 13.24:    F. Hoffmann-La Roche Ltd: Product Portfolio
Figure 13.25:    F. Hoffmann-La Roche Ltd: Overall Financials, 2017-2019
Figure 13.26:    F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2017-2019
Figure 13.27:    F. Hoffmann-La Roche Ltd: Revenue (by Region), 2017-2019
Figure 13.28:    F. Hoffmann-La Roche Ltd: R&D Expenditure, 2017-2019
Figure 13.29:    F. Hoffmann-La Roche Ltd: SWOT Analysis
Figure 13.30:    GE Healthcare: Product Portfolio
Figure 13.31:    General Electric Company: Overall Financials, 2016-2018
Figure 13.32:    General Electric Company: Revenue (by Segment), 2016-2018
Figure 13.33:    General Electric Company: Revenue Split for Healthcare, 2016-2018
Figure 13.34:    General Electric: Healthcare Revenue (by Region), 2016-2018
Figure 13.35:    General Electric Company: R&D Expenditure, 2016-2018
Figure 13.36:    General Electric Company: SWOT Analysis
Figure 13.37:    GENEWIZ, Inc.: Overall Service Portfolio
Figure 13.38:    GENEWIZ, Inc.: SWOT Analysis
Figure 13.39:    Illumina, Inc.: Overall Product Portfolio
Figure 13.40:    Illumina, Inc.: Overall Financials, 2016-2018
Figure 13.41:    Illumina, Inc.: Revenue (by Segment), 2016-2018
Figure 13.42:    Illumina, Inc.: Revenue (by Region), 2016-2018
Figure 13.43:    Illumina, Inc.: R&D Expenditure, 2016-2018
Figure 13.44:    Illumina, Inc.: SWOT Analysis
Figure 13.45:    Laboratory Corporation of America Holdings: Overall Product Portfolio
Figure 13.46:    Laboratory Corporation of America Holdings: Overall Financials, 2016-2018
Figure 13.47:    Laboratory Corporation of America Holdings: Revenue (by Segment),  2016-2018
Figure 13.48:    Laboratory Corporation of America Holdings: Revenue (by Region), 2018
Figure 13.49:    Laboratory Corporation of America Holdings: SWOT Analysis
Figure 13.53:    Pacific Biosciences of California, Inc.: Overall Product Portfolio
Figure 13.54:    Pacific Biosciences of California, Inc.: Overall Financials, 2016-2018
Figure 13.56:    Pacific Biosciences of California, Inc.: Revenue (by Region), 2016-2018
Figure 13.57:    Pacific Biosciences of California, Inc.: R&D Expenditure, 2016-2018
Figure 13.58:    Pacific Biosciences of California, Inc.: SWOT Analysis
Figure 13.59:    QIAGEN N.V.: Product Portfolio
Figure 13.60:    QIAGEN N.V.: Overall Financials, 2016-2018
Figure 13.61:    QIAGEN N.V.: Revenue (by Segment), 2016-2018
Figure 13.62:    QIAGEN N.V.: Revenue (by Region), 2016-2018
Figure 13.63:    QIAGEN N.V.: R&D Expenditure, 2016-2018
Figure 13.64:    QIAGEN N.V.: SWOT Analysis
Figure 13.65:    Thermo Fisher Scientific Inc.: Product Portfolio
Figure 13.66:    Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
Figure 13.67:    Thermo Fisher Scientific Inc.: Revenue (by Segment), 2016-2018
Figure 13.68:    Thermo Fisher Scientific Inc.: Revenue (by Region), 2016-2018
Figure 13.69:    Thermo Fisher Scientific Inc.: R&D Expenditure, 2016-2018
Figure 13.70:    Thermo Fisher Scientific Inc.: SWOT Analysis

You may also like

Published Year: 2019

Global NGS-Based Monitoring and Diagnostic Test Market: Focus on Application, Method, Type, End User

The global NGS based monitoring and diagnostic test market to grow at a significant CAGR of...

 
Published Year: 2019

Global Next-Generation Sequencing Market: Focus on Products and Services, Applications, Technology,

In 2018, the global next-generation sequencing market was valued at $4.93 billion and is...

 

Global Whole Genome and Exome Sequencing Market

Focus on Product, Workflow, Application, End User, Country Data (16 Countries), and Competitive Landscape - Analysis and Forecast, 2019-2029